Radiolabeled compounds for thrombus imaging

Details Radiolabeled compounds for thrombus imaging Radiolabeled compounds for thrombus imaging

1998-06-19

2000-02-08

Davenport, Avis M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 13, 514 14, 514 15, 514 16, 514 17, 514 18, 424 169, 424 111, 424 165, A61K 3800, C07K 500, C07K 700

Patent

active

060228571

ABSTRACT:
This invention relates to radiolabeled scintigraphic imaging agents, and methods and reagents for producing such agents. Specifically, the invention relates to specific binding compounds, including peptides, that bind to a platelet receptor that is the platelet GPIIb/IIIa receptor, methods and kits for making such compounds, and methods for using such compounds labeled with technetium-99m via a covalently-linked radiolabel-binding moiety to image thrombi in a mammalian body.

REFERENCES:
patent: 5443815 (1995-08-01), Dean et al.
patent: 5508020 (1996-04-01), Dean et al.
patent: 5552525 (1996-09-01), Dean
patent: 5645815 (1997-07-01), Dean et al.
patent: 5736122 (1998-04-01), Dean et al.

Affiliated with

Also associated with

Rating

Radiolabeled compounds for thrombus imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radiolabeled compounds for thrombus imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled compounds for thrombus imaging will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1681571